Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Hall

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Plos One|September 1, 2022
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancerBrian T Helfand, Michael Paterakos, Chi-Hsiung Wang, et al.
JCO Precision Oncology|June 7, 2023
Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced CancerSarah N Gibbs, Desi Peneva, Gebra Cuyun Carter, et al.
Plos Biology|July 1, 2024
Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effectsYevgeniy Plavskin, Maria Stella de Biase, Naomi Ziv, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effectsYevgeniy Plavskin, Maria Stella de Biase, Naomi Ziv, et al.
Journal of Surgical Oncology|January 26, 2025
Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT StudyBrenda Diergaarde, Greg Young, David W Hall, et al.
The Oncologist|June 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancerMadappa N Kundranda, Ariane C Kemkes, Mark C Evans, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Genome Biology|October 7, 2020
A genome assembly and the somatic genetic and epigenetic mutation rate in a wild long-lived perennial Populus trichocarpaBrigitte T Hofmeister, Johanna Denkena, Maria Colomé-Tatché, et al.
Elife|October 17, 2018
Firefly genomes illuminate parallel origins of bioluminescence in beetlesTimothy R Fallon, Sarah E Lower, Ching-Ho Chang, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Plos One|September 1, 2022
The 17-gene Genomic Prostate Score assay as a predictor of biochemical recurrence in men with intermediate and high-risk prostate cancerBrian T Helfand, Michael Paterakos, Chi-Hsiung Wang, et al.
JCO Precision Oncology|June 7, 2023
Comprehensive Review on the Clinical Impact of Next-Generation Sequencing Tests for the Management of Advanced CancerSarah N Gibbs, Desi Peneva, Gebra Cuyun Carter, et al.
Plos Biology|July 1, 2024
Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effectsYevgeniy Plavskin, Maria Stella de Biase, Naomi Ziv, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Spontaneous single-nucleotide substitutions and microsatellite mutations have distinct distributions of fitness effectsYevgeniy Plavskin, Maria Stella de Biase, Naomi Ziv, et al.
Journal of Surgical Oncology|January 26, 2025
Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α-CORRECT StudyBrenda Diergaarde, Greg Young, David W Hall, et al.
The Oncologist|June 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancerMadappa N Kundranda, Ariane C Kemkes, Mark C Evans, et al.
Oncotarget|July 25, 2025
Comprehensive genomic profiling of over 10,000 advanced solid tumorsJean-Paul De La O, Jess R Hoag, Angela K Deem, et al.
Journal of Medical Economics|March 31, 2026
Costs and benefits of whole-exome, whole-transcriptome sequencing versus 50-gene panels for genomic profiling in solid tumorsJesse D Ortendahl, Gebra Cuyun Carter, Eliza M Zantema, et al.
Genome Biology|October 7, 2020
A genome assembly and the somatic genetic and epigenetic mutation rate in a wild long-lived perennial Populus trichocarpaBrigitte T Hofmeister, Johanna Denkena, Maria Colomé-Tatché, et al.
Elife|October 17, 2018
Firefly genomes illuminate parallel origins of bioluminescence in beetlesTimothy R Fallon, Sarah E Lower, Ching-Ho Chang, et al.
Pageof 5